Statins and renal function

Area of Science:

• Nephrology
• Cardiology
• Pharmacology

Background:

• Renal disease elevates vascular event and atherosclerosis risk due to factors like dyslipidemia, hypertension, and diabetes.
• Impaired renal function itself is an independent predictor of vascular risk.
• Established risk factors and other predictors like homocysteine and lipoprotein(a) are often elevated in renal disease patients.

Purpose of the Study:

• To review existing evidence on the beneficial effects of statins in patients with various renal diseases.
• To explore potential mechanisms by which statins may improve renal outcomes and cardiovascular health.
• To consider drug interactions and pharmacokinetic changes relevant to statin use in impaired renal function.

Main Methods:

• Review of experimental and clinical evidence regarding statin use in renal disease.
• Analysis of studies examining statin effects on renal function, proteinuria, and blood pressure.
• Consideration of pharmacokinetic data and drug interactions.

Main Results:

• Statins show potential benefits including improved renal function and decreased microalbuminuria.
• Evidence suggests statins may lower blood pressure and improve renal allograft survival.
• Mechanisms of action and interactions with common comorbidities are discussed.

Conclusions:

• Statins may offer significant benefits for patients with renal disease, impacting both renal and cardiovascular outcomes.
• Further investigation is urgently needed to define the role of statins in this population.
• Determining the optimal statin and managing potential drug interactions are critical next steps.